HMVAX
Price
$15.67
Change
-$0.24 (-1.51%)
Updated
Nov 13 closing price
Net Assets
1.11B
VMVIX
Price
$68.49
Change
-$0.77 (-1.11%)
Updated
Nov 13 closing price
Net Assets
31.8B
Interact to see
Advertisement

HMVAX vs VMVIX

Header iconHMVAX vs VMVIX Comparison
Open Charts HMVAX vs VMVIXBanner chart's image
Hartford MidCap Value A
Price$15.67
Change-$0.24 (-1.51%)
VolumeN/A
Net Assets1.11B
Vanguard Mid-Cap Value Index Investor
Price$68.49
Change-$0.77 (-1.11%)
VolumeN/A
Net Assets31.8B
HMVAX vs VMVIX Comparison Chart in %
View a ticker or compare two or three
VS
HMVAX vs. VMVIX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVAX is a Hold and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 31.8B vs. HMVAX (1.11B). VMVIX pays higher dividends than HMVAX: VMVIX (2.08) vs HMVAX (0.68). HMVAX was incepted earlier than VMVIX: HMVAX (25 years) vs VMVIX (19 years). HMVAX (1.14) is less costly to investors than VMVIX (0.19). HMVAX is a more actively managed with annual turnover of: 132.00 vs. VMVIX (19.00). HMVAX has a lower initial minimum investment than VMVIX: HMVAX (2000) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 1.67 vs. HMVAX (-14.46). VMVIX return over 5 years is better than : 54.76 vs. HMVAX (14.77).
HMVAXVMVIXHMVAX / VMVIX
Total Expense Ratio1.140.19600%
Annual Report Gross Expense Ratio1.140.19600%
Fund Existence25 years19 years-
Gain YTD0.9017.64112%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B31.8B4%
Annual Yield % from dividends0.682.0833%
Returns for 1 year-14.461.67-864%
Returns for 3 years-4.0026.76-15%
Returns for 5 years14.7754.7627%
Returns for 10 years6.16103.206%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GILD125.201.80
+1.46%
Gilead Sciences
PTCT74.95N/A
N/A
PTC Therapeutics
BY27.30-0.20
-0.73%
Byline Bancorp
BZAI2.54-0.07
-2.68%
Blaize Holdings Inc
NOTV1.05-0.07
-6.25%
Inotiv